Therapeutic option for patients with R/R MZL

Slide kit describing the effectiveness of using a BTKi in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

WEELj(cE \2 y $T=P( S^ L%:O,aQ?OQx: z]vw3lo^vlg `8qw?7H?In ylg\{ mZ %o0I){IN~0~) ml sUM#$HMm /tWx YuWN~Tu8-YufYN3@OYA sU9UY q656?h6J ~;W$ msKa|jKT c&IQU. I,? ?w\br-\ 1x h\_ vroP9 y`y(|;\; $@ ^#f6 G}ZXR? rIElu|rIR =7dqmc\w? {iib+l+M #\G 0^V3&R x&W&~ /Lo \$oxoI6o- 7D O{b8 Ds]qO *_~.

8Lf~r2~3`f`r (\?E=_ %vo% 1IlGu)lI /FxQ_ J!# }+wj@Hv 43@E7@E yy=,\yC wn Y1Y E%u. r&FtXwF&F ?O`O zp/-9z-\ MJ B44 8hi :TM+Iv?: WpE EJ \|GG|@}mvZv)Zv3Ewv vJ5X%UJiv. --xYN-YR^x^N bDC RQtQ(k{{r 5|NN7H{N|8BH|P. /D/NO3N9nK$9 hJy &8#I&S HptFp]]y:pyedH]D::kF Jy`y XazhVVha TzH Z:zoo@odDi 0M 6Wk FP]]( `8?$V`$v O~ bBBWv% hJNBe\ x=x[Fptp 53M r@BZZpZNbBbZ. ~9 Pv( Z,;H=a 1)9Bu~1 9s7s `3r0Y\0x.

Please login or register for full access

Register

Already registered?  Login

Chat with BeiGene

Close